Microsaic Systems plc Notice of AGM

RNS Number : 1620M

Microsaic Systems plc

14 November 2024

 

14 November 2024

                                                                                                                                                                                                                               

Microsaic Systems plc

 

("Microsaic", "Microsaic Systems" or the "Company")

 

Notice of Annual General Meeting

 

Microsaic Systems plc (AIM: MSYS), an international developer and provider of testing solutions for unique and underserved public health and environmental markets, announces that its Notice of Annual General Meeting ("Notice of AGM") is now available on the Company's website at https://www.microsaic.com/investors/#documents

 

The Notice of AGM will be posted to shareholders today, together with the Form of Proxy for voting at the Annual General Meeting ("AGM").

 

The Company will hold its AGM at the offices of Turner Pope Investments (TPI) Limited (the Company's joint broker) at 3 Queen Street, London, W1J 5PA on 11 December 2024 at noon.

 

 

Enquiries:

 

Microsaic Systems plc Bob Moore, Acting Executive Chairman	[phone] via TPI
Singer Capital Markets (Nominated Adviser & Joint Broker) Alex Bond / Oliver Platts	[phone]
Turner Pope Investments (TPI) Limited (Joint Broker) Andy Thacker / James Pope	[phone]

 

 

About Microsaic Systems

 

Microsaic is highly experienced in the development, manufacture and supply of microelectronics instrumentation for markets requiring analytical testing in public and environmental health markets. The Company has recently acquired and integrated the assets of Modern Water with Microsaic Systems' technologies resulting in comprehensive water testing and other toxic testing capabilities.

 

Microsaic's products and solutions are commercially available through global markets via a network of regional and country specific distributors and partners.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

NOABJBPTMTBBBRI